<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02727504</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00896-43</org_study_id>
    <secondary_id>35RC15_9884_LOWAS</secondary_id>
    <nct_id>NCT02727504</nct_id>
  </id_info>
  <brief_title>Low Flow Low Gradient Aortic Stenosis Relevance of the (re)Search for a Contractile Reserve</brief_title>
  <acronym>LOWAS</acronym>
  <official_title>Low Flow Low Gradient Aortic Stenosis Relevance of the (re)Search for a Contractile Reserve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators sought to demonstrate that the increase in the stroke volume during a
      dobutamine stress echocardiography might impact the prognosis of a patient addressed for a
      low flow low gradient suspected severe aortic valve stenosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 11, 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of death of all cause</measure>
    <time_frame>Month 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of emergent hospitalization for any cardiovascular reason</measure>
    <time_frame>Month 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death (all causes)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency Cardiovascular hospitalization</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in left ventricular ejection fraction (LVEF), in global longitudinal strain in 2D and or 3D echocardiography</measure>
    <time_frame>Inclusion, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms evolution</measure>
    <time_frame>Inclusion, 12 months</time_frame>
    <description>6-minute walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms evolution</measure>
    <time_frame>Inclusion, 12 months</time_frame>
    <description>Duke Activity Score</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">115</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Patient with aortic valve stenosis</arm_group_label>
    <description>115 patients will undergo a medical examination in order to analyse their medical history, cardiovascular parameters and check inclusion and non-inclusion criterions.
Then will be performed :
An electrocardiogram
2D and 3D echocardiography
Dobutamine stress echocardiography
Blood tests : blood electrolytes, creatinine, hemoglobin, N-terminal pro-brain natriuretic peptide (NT-ProBNP), C reactive protein (CRP), soluble suppression of tumorigenicity-2 (ST-2)
A cardiac MRI
A cardiac scanner
A 6-minutes walking test
An evolution of the Duke Activity Score</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrocardiogram</intervention_name>
    <description>ECG at inclusion and M12</description>
    <arm_group_label>Patient with aortic valve stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2D and 3D echocardiography</intervention_name>
    <description>2D and 3D echocardiography at inclusion and M12</description>
    <arm_group_label>Patient with aortic valve stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dobutamine stress echocardiography</intervention_name>
    <description>dobutamine stress echocardiography at inclusion</description>
    <arm_group_label>Patient with aortic valve stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood tests</intervention_name>
    <description>Blood test electrolytes, creatinine, hemoglobin, NT-proBNP, CRP, ST-2 at inclusion and M12</description>
    <arm_group_label>Patient with aortic valve stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac MRI</intervention_name>
    <description>Cardiac MRI at inclusion</description>
    <arm_group_label>Patient with aortic valve stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac scanner</intervention_name>
    <description>Cardiac scanner at inclusion</description>
    <arm_group_label>Patient with aortic valve stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>6-minutes walking test</intervention_name>
    <description>6-minutes walking test at inclusion and M12</description>
    <arm_group_label>Patient with aortic valve stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Duke Activity Score</intervention_name>
    <description>Duke Activity Score at inclusion and M12</description>
    <arm_group_label>Patient with aortic valve stenosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with low flow low gradient aortic stenosis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient from 45 to 90 years old

          -  Patient agreeing freely to participate in the study

          -  Aortic surface area suspected to be &lt; 1 cm² or &lt; 0.6 cms²/m²

          -  Low aortic gradient defined by a mean pressure gradient &lt; 40 mmHg

          -  Aortic low flow defined by: a stroke volume indexed &lt; 35 ml/m2

          -  Any contra-indication for the realization of the MRI

        Exclusion Criteria:

          -  Heart rhythm disorders

          -  Presence of comorbidity altering the 2-year prognosis of a patient (cancer, terminal
             renal insufficiency (GFR 30 ml / min / 1,73m2), liver cirrhosis, respiratory
             insufficiency (VEMS 1 L)

          -  Presence of a concomitant valvular heart disease with stenosis or regurgitation &gt;
             moderated

          -  Persons subject to major legal protection (safeguarding justice, guardianship,
             trusteeship), persons deprived of liberty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Erwan Donal, MD, PhD</last_name>
    <phone>02 99 28 94 75</phone>
    <email>erwan.donal@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erwan Donal, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2016</study_first_submitted>
  <study_first_submitted_qc>March 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2016</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic valve stenosis</keyword>
  <keyword>low flow</keyword>
  <keyword>dobutamine stress echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dobutamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

